Linda Pissott Reig, shareholder in the firm's FDA & Biotechnology section, comments on the FDA's move to enable AI-based medical devices to make reactive decisions, instead of decisions locked by manufacturers, in Legaltech News' article "FDA Considers Less Restrictive Protocols for Some AI-Based Medical Devices."